Nobel Biocare Upgraded by Goldman Sachs to “Neutral” (NBHGY)
Nobel Biocare (NASDAQ:NBHGY) was upgraded by investment analysts at Goldman Sachs from a “sell” rating to a “neutral” rating in a note issued to investors on Thursday, TheFlyOnTheWall.com reports.
Shares of Nobel Biocare (NASDAQ:NBHGY) traded up 2.49% during mid-day trading on Thursday, hitting $6.99. 100 shares of the company’s stock traded hands. Nobel Biocare has a 52 week low of $5.51 and a 52 week high of $8.51. The stock has a 50-day moving average of $7.09 and a 200-day moving average of $7.5. The company has a market cap of $1.718 billion and a P/E ratio of 28.90.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.